Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers

Clinical Drug Investigation

Volumn 26, Issue 1, 2006, Pages 21-28

  Tolman, Keith G ^a,f   Täubel, Jörg ^b   Warrington, Steven ^c   Chiu, Yi Lin ^d   Pilmer, Betsy L ^e   Pan, Wei Jian ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Charterhouse Clinical Research Unit   (United Kingdom)

^c Hammersmith Medicines Research Limited and Trio Medicines Limited   (United Kingdom)

^d ABBOTT LABORATORIES   (United States)

^e TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; RABEPRAZOLE;

ACID SECRETION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; MALE; NORMAL HUMAN; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; VOLUNTEER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; ANTI-ULCER AGENTS; AREA UNDER CURVE; CROSS-OVER STUDIES; ENZYME INHIBITORS; FEMALE; GASTRIC ACIDITY DETERMINATION; HUMANS; MALE;

EID: 30744460126     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626010-00003     Document Type: Article

References (18)

1. Burget DW, Stephen G, Chiverton SG, et al. Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-51
2. Bell NJ, Burget D, Howden C, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1993; 51 Suppl. 1: 59-67
3. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-810
4. Bell NJ, Hunt RH. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers. Aliment Pharmacol Ther 1996; 10: 897-904
5. Blum RA, Shi H, Karol M, et al. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. Clin Ther 1997; 19: 1013-23
6. Takeda H, Hokari K, Asaka M. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-h intragastric pH monitoring. J Clin Gastroenterol 1995; 20 Suppl. 1: S7-9
7. Bruley des Varannes S, Levy P, Lartigue S, et al. Comparison of lansoprazole with omeprazole on 24-h intragastric pH, acid secretion, and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994; 8 (3): 309-14
8. Dammann HG, Fuchs W, Richter G, et al. Influence of lansoprazole 15mg and omeprazole 20mg and 40mg on meal-stimulated gastric acid secretion. Aliment Pharmacol Ther 1997; 11: 359-64
9. Tolman KG, Sanders SW, Buchi KN, et al. The effects of oral doses of lansoprazole and omeprazole on gastric pH. J Clin Gastroenterol 1997; 24: 65-70
10. Hussein Z, Granneman GR, Mukherjee D, et al. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br J Clin Pharmacol 1993; 36: 391-8
11. Regardh GG. Pharmacokinetics and metabolism of omeprazole in man. Scand J Gastroenterol 1991; 21 Suppl. 118: 99-104
12. Williams MR, Sercombe J, Hamilton MI, et al. A placebo-controlled trial to assess the effects of 8 Days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastric concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998; 12: 1079-89
13. Gardner JD, Rodriquez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 1363-70
14. Gardner JD, Perdomo C, Sloan S, et al. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther 2002; 16: 455-64
15. Metropolitan Life Insurance Company. Stat Bulletin 1983; 2-9
16. Kahrilas PJ. Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am 1997; 26 (3): 467-86
17. Miner P, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003; 98: 2616-20
18. Pantoflickova D, Dorta G, Ravic M, et al. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther 2003; 17: 1507-14